Okemoto, D., Kotani, D., Kubo, Y., Sato, K., Nakamura, M., Sakashita, S., Mishima, S., Shitara, K., Kojima, T., Fujita, T. (2026). A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.tps471